Research Initiatives

Status · Active

Where clinical trial demand is heading, where capacity isn't keeping up, concurrent trial load per site, and the workforce behind execution. Quantitative work on the US and global trial ecosystem using ClinicalTrials.gov/AACT, FDA approvals, and public funding sources.

Status · Active · Publications forthcoming

Site intelligence and capacity analysis outside the United States. First-pass work focuses on Brazil (integrating DATASUS public-health data with ClinicalTrials.gov) and the broader Latin American research landscape — mapping where studies are conducted, by whom, and at what scale, in markets where published site data is sparse.

Analytical outputs expected 2026–2027. Interim findings will appear in Notes as they are completed.

Status · Active

Patient recruitment, matching, and retention; privacy regulations and consent systems; patient relationship management; and the design of trial communications that respect patient autonomy. Where clinical research meets the people who make it possible.

Status · Active · Models published alongside tools

The methodology and models behind our open tools — enrollment simulation, speed-vs-access life-years modeling, scenario comparison, synthetic controls, and digital twins. We publish the models so that assumptions can be examined, criticized, and improved.

Status · Active

Regulatory analysis, HHS and FDA guidance, Diversity Action Plans, and administration transitions. How the policy environment shapes what trials get run, who can participate, and under what rules.